Dr. Yaron has co-founded and served as chairman of P-cube and PentaCom, (both sold to Cisco), Comsys (landline business sold to Conexant, wireless sold to Texas Instruments), Qumranet (sold to RedHat) and as chairman of the board of Mercury Interactive (sold to HP for $4.9B).
Dr. Yaron currently serves on the board of Amdocs (DOX) and advisory board of Raphael and serves as the chairman of the Executive Council, Tel Aviv University, and on the board of governors and executive committee of the Hebrew University.
From 1992-1995 Dr. Yaron has served as President of Indigo NV (sold to HP). Prior to joining Indigo he served as corporate vice president of National Semiconductor and general manager of its Israeli operations with worldwide responsibility for its microprocessor business.
Dr. Yaron holds a Ph.D. in Device Physics from the Hebrew University, has published over twenty scientific papers and holds six patents.
In addition to serving as Co-Chairman of Itamar Medical, Mr. Gerstel is chairman of Compugen (NASDAQ and TASE: CGEN), Evogene (TASE:EVGN), and Keddem Bioscience. Prior to relocating to Israel in 1994, Mr. Gerstel was the Co-Chairman and CEO of ALZA Corporation (sold to Johnson & Johnson).
Mr. Gerstel currently serves as a director of YEDA (the technology transfer company for the Weizmann Institute of Science), Yissum (the technology transfer company of the Hebrew University) and the Foundation for the US National Medals of Science and Technology. He is a member of the board of governors and the executive committee of the Weizmann Institute of Science and the board of governors of the Hebrew University, and is an advisor to the Burrill Life Science Funds and to the board of the Israel-U.S. BiNational Industrial Research and Development ("BIRD") Foundation.
Mr. Gerstel is a graduate of Yale University and Stanford Graduate School of Business.
Mr. Ellis has served Medtronic (NYSE: MDT) for almost 2 decades in various managerial positions, culminating in his current position of Senior Vice President and Chief Financial Officer.
Prior to joining Medtronic, Mr. Ellis was a Senior Audit Manager for Price Waterhouse. He has worked with several large corporate organizations, as well as providing audit services to numerous non-profit organizations.
Mr. Ellis is a member of the TORO Company Board. He served as the Chairman of the American Heart Association Board in 2007-2008.
Mr. Ellis received his bachelor's of science degree in Accounting in 1978 from the University of South Dakota. He is very active in community and volunteer activities.
Steven B. Ruchefsky, is employed by Caremi Partners Ltd., a private investment company and significant shareholder of the company. Since September 2001, Mr. Ruchefsky has been working with the founder and current manager of a multi-billion dollar hedge fund.
Mr. Ruchefsky began his career at a prominent New York City law firm where he became a partner, member of management and chair of a specialized litigation group. Upon leaving his law firm and prior to his employment by Caremi Partners Ltd., Mr. Ruchefsky was a principal of an early stage venture capital operation.
Mr. Ruchefsky currently on the boards of several public and private companies: National Investment Managers Inc. (NIVM:OB); Evogene (TASE:EVGN); LantiBio, Inc.; and Canoil Inc.
Mr. Ruchefsky, is a graduate of The George Washington University Law School, Washington D.C.
Outside advisor to the Ophir Katz & co., Law Office , Chair person and a member of the board of directors of the Audit Committee of the Bank of Jerusalem Ltd.
Mrs. Miri Katz is a member of other boards of directors of the following companies: Tower Semiconductor Ltd., the Caesarea Fund and the Edmond de Rothschild Caesarea development Company Ltd
Professor at the management Faculty of the Tel-Aviv University, Chairman Of The Professional Committee Of The Tel-Aviv-Jaffa Academic College, in charge of The Goldreigh Chair Of International Banking At He Tel-Aviv University , Chairman of The Tel-Aviv Stock Exchange Ltd., President Of The International Union Of Option Exchanges , Member Of The Israeli-America Fund Board Of Directors .
Professor Orgler is a member of the board of directors of the following companies: Bank Hapoalim B.M., Israeli Chemicals Ltd., Brom Yam Amelachltd., Tirkovot Brom Ltd., Sargon Ltd., Atidim-Hi-Tech Industries Ltd.
S. Morry Blumenfeld retired from GE Medical Systems in 2002 after more than 34 years with the company, during which he helped initiate the CT and MRI business as well as being responsible for Advanced Development. His final appointment was as Managing Director of GE Medical Systems Israel after GE bought a number of Israeli companies in the 1998 time frame. He is currently one of the Founding Partners of Meditech Partners which has been investing in US and Israeli medical device companies through a number of funds. A prominent authority on development of healthcare technology he serves on a number of academic advisory boards, as well as the Board of Governors of the Hebrew University and its Technology Transfer Company. He is on the Board of a number of public companies, including Aposense, MAKO Surgical and Oridion, as well as number of private medical device and technology companies. Dr Blumenfeld earned his BASc in Engineering Physics and PhD in Molecular Physics from the University of Toronto.
Former Vice Chairman Medtronic Inc. (NYSE: MDT)